查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009389

睡眠呼吸中止症治疗设备市场规模、份额、趋势和预测：按产品类型、最终用户和地区划分，2026-2034年

Sleep Apnea Devices Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球睡眠呼吸中止症治疗设备市场规模为90亿美元。预计到2034年，该市场规模将达到145亿美元，2026年至2034年的复合年增长率（CAGR）为5.44%。北美目前在该市场主导，预计2025年市占率将达到49.2%。越来越多的人寻求治疗以改善睡眠品质和整体健康状况，这推动了对睡眠呼吸中止症治疗设备的需求。此外，能够追踪治疗效果的产品创新也进一步促进了睡眠呼吸中止症治疗设备市场的成长。

由于肥胖、压力和久坐不动的生活方式等因素，睡眠相关疾病（尤其是阻塞型睡眠呼吸中止症（OSA））的盛行率不断上升，推动了对持续性正压呼吸器（CPAP）机、面罩和口腔矫正器等设备的需求。此外，人们越来越意识到未经治疗的睡眠呼吸中止症会带来心血管疾病、高血压和糖尿病等慢性健康风险，这促使更多患者儘早接受干预。医疗基础设施的改善和睡眠诊断实验室的普及也促进了市场成长。此外，携带式、使用者友善和连网设备等技术的进步也提高了患者的治疗依从性。

由于多种因素，美国正崛起为睡眠呼吸中止症设备市场的重要区域。阻塞型睡眠呼吸中止症（OSA）盛行率的不断上升正在推动睡眠呼吸中止症治疗设备市场的成长。一项在美国进行的调查预测，到2024年，美国将有约8060万人患有OSA，其中男性47623848人（占59%），女性32967117人（占41%）。人们对心血管疾病、中风和糖尿病等疾病未经治疗所带来的风险的认识不断提高，进一步推动了对诊断和治疗设备的需求。 CPAP设备、面罩和口腔矫正器的保险覆盖和报销政策也为市场准入提供了支援。

睡眠呼吸中止症治疗设备市场趋势：

睡眠呼吸中止症病例数增加

睡眠呼吸中止症的高发生率为睡眠呼吸中止症治疗设备市场带来了有利前景，因为这增加了需要正确诊断和有效治疗的患者数量。根据美国国家生物技术资讯中心（NCBI）预测，到2025年，阻塞型睡眠呼吸中止症（OSA）预计将影响全球约9.36亿30至69岁的成年人。肥胖、压力和久坐等生活方式因素显着增加了OSA的风险，从而导致对持续气道正压通气（CPAP）和双水平气道正压通气（BiPAP）等治疗设备的需求增加。睡眠呼吸中止症若不及时治疗，可能导致严重的健康併发症，包括高血压、心血管疾病、糖尿病和生产力下降，促使患者和医疗专业人员寻求早期疗育。医疗协会和医疗机构所进行的宣传活动提高了诊断率，从而扩大了设备应用人群。

产品创新

睡眠呼吸中止症治疗设备市场的一个关键趋势是产品创新，其中包括用于检测睡眠模式和呼吸参数以诊断阻塞性睡眠呼吸中止症（OSA）的「非中心（OOC）」测试设备。 2025年1月，英国国家卫生与临床优化研究所（NICE）核准了Acurable公司的「AcuPebble」设备在英国国家医疗服务体系（NHS）的应用。这使得患者可以在家中进行自动化OSA诊断，从而减少了对医疗机构睡眠评估的依赖。最新的设备采用静音马达、符合人体工学的面罩设计、高度便携的结构以及无线连接功能，支援远端监测并与数位健康平台整合。这些功能提高了患者的治疗依从性，并使医生能够即时追踪治疗效果。各公司也在投资研发便于旅行使用的微型设备以及将诊断和治疗整合到单一系统中的混合解决方案。这些产品创新不仅改善了患者体验，而且透过鼓励更多人接受治疗，扩大了市场。

政府监理范围扩大

严格的政府监管确保了产品的安全性、品质和有效性，从而建立了病人和医生之间的信任。监管机构强制要求遵守有关设备性能、卫生和用户安全的严格准则，鼓励製造商创新并保持高标准。 2025年4月，瑞思迈（ResMed）在美国推出了获得FDA核准的家庭睡眠呼吸中止症检测套组NightOwl。这款指尖感应器设备可提供自动评分结果、远端分析和简化的阻塞性睡眠呼吸中止症（OSA）诊断。严格的感染控制、临床试验和上市后监测准则在保护病患健康的同时，也防止了不合格产品流入市场。遵守法规有助于提升值得信赖的品牌的信誉，并促进其在医院、诊所和居家医疗机构中的应用。总而言之，政府监管透过促进创新和提高睡眠呼吸中止症治疗的安全性，正在增强整个市场。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球睡眠呼吸中止症治疗设备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品类型划分

  • 用于治疗的医疗设备
    • 市场区隔：按类型
      • 正压通气（PAP）设备
      • 口腔装置
      • 鼻腔装置
      • 下巴带
      • 其他的
  • 诊断设备
    • 市场区隔：按类型
      • 活动记录器
      • 睡眠多导图仪
      • 睡眠筛检设备
      • 其他的

第七章 市场区隔：依最终用户划分

  • 医院和诊所
  • 睡眠测试机构
  • 居家医疗环境
  • 其他的

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他的
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 伊朗
    • 阿拉伯聯合大公国
    • 其他的

第九章 SWOT 分析

第十章：价值链分析

第十一章：波特五力分析

第十二章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • BMC Medical Co.
    • Braebon Medical Corporation
    • Cadwell Laboratories Inc.
    • CareFusion Corp.
    • Curative Medical Inc.
    • Devilbiss Healthcare
    • Fisher & Paykel Healthcare
    • GE Healthcare
    • Invacare
    • Oventus Medical
    • Panthera Dental
    • ResMed
    • Somnomed Ltd.
    • Vyaire Medical Inc.
    • Whole You Inc.
Product Code: SR112026A1863

The global sleep apnea devices market size was valued at USD 9.0 Billion in 2025. The market is projected to reach USD 14.5 Billion by 2034, exhibiting a CAGR of 5.44% from 2026-2034. North America currently dominates the market, holding a market share of 49.2% in 2025. With an increasing number of individuals seeking treatment to improve sleep quality and health outcomes, the demand for sleep apnea devices is rising. Product innovations, which aid in tracking therapy effectiveness, are propelling the sleep apnea devices market share.

The growing incidence of sleep-related disorders, especially obstructive sleep apnea (OSA), due to factors like obesity, stress, and sedentary lifestyles is catalyzing the demand for devices, such as continuous positive airway pressure (CPAP) machines, masks, and oral appliances. Besides this, rising awareness about the chronic health dangers linked to neglected sleep apnea, including cardiovascular disease, hypertension, and diabetes, is encouraging more patients to seek timely intervention. Expanding healthcare infrastructure and greater accessibility to diagnostic sleep labs are also supporting the market growth. Additionally, technological advancements like portable, user-friendly, and connected devices are improving patient compliance.

The United States has emerged as a major region in the sleep apnea devices market owing to many factors. Increasing incidence of OSA is fueling the sleep apnea devices market growth. As per a study conducted in the United States, an estimated 80.6 Million people were projected to have OSA in 2024, including 47,623,848 (59%) males and 32,967,117 (41%) females. The heightened consciousness about the dangers linked to untreated aliments, such as cardiovascular disease, stroke, and diabetes, is further catalyzing the demand for diagnostic and therapeutic devices. Insurance coverage and reimbursement policies for CPAP machines, masks, and oral appliances are supporting market accessibility.

SLEEP APNEA DEVICES MARKET TRENDS:

Growing incidence of sleep apnea cases

The high prevalence of sleep apnea cases is offering a favorable sleep apnea devices market outlook, as rising numbers of patients require timely diagnosis and effective treatment. NCBI reports that in 2025, OSA is set to impact around 936 Million adults globally aged 30 to 69. Lifestyle factors, such as obesity, stress, and sedentary routines, significantly increase the risk of OSA, leading to higher demand for therapeutic devices like CPAP and bilevel positive airway pressure (BiPAP) machines. Left untreated, sleep apnea can result in severe health complications, including hypertension, cardiovascular disease, diabetes, and reduced productivity, which is leading patients and healthcare providers towards early intervention. The growing awareness campaigns by medical associations and healthcare institutions have improved diagnosis rates, thereby expanding the patient base for device adoption.

Innovations in products

Product innovations, including out-of-center (OOC) testing devices that examine sleep patterns and respiratory parameters for the diagnosis of OSA, are among the major sleep apnea devices market trends. In January 2025, NICE endorsed the AcuPebble device from Acurable for NHS implementation, allowing at-home automated diagnosis of OSA and lessening dependence on in-clinic sleep assessments. Modern devices feature quieter motors, ergonomic mask designs, portable structures, and wireless connectivity, enabling remote monitoring and integration with digital health platforms. These features enhance patient adherence and allow physicians to track therapy effectiveness in real-time. Companies are also investing in miniaturized devices for travel use and hybrid solutions combining diagnostics and therapy in one system. Such product innovations are not only improving patient experiences but also expanding the market by attracting more individuals to adopt treatment.

Rising implementation of government regulations

Stringent regulations by governments are ensuring product safety, quality, and effectiveness, which is boosting patient and physician trust. Regulatory bodies mandate compliance with stringent guidelines for device performance, hygiene, and user safety, encouraging manufacturers to innovate and maintain high standards. In April 2025, Resmed launched NightOwl, an FDA-cleared home sleep apnea test across the US. The fingertip sensor device offered auto-scored results, remote analysis, and simplified OSA diagnosis. Stringent guidelines on infection control, clinical trials, and post-market surveillance safeguard patient well-being while preventing substandard products from entering the market. Compliance helps build credibility for trusted brands and expands adoption in hospitals, clinics, and homecare settings. Overall, government regulations are strengthening the overall market by driving innovations and enhancing the safety of sleep apnea therapies.

SLEEP APNEA DEVICES INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Therapeutic Devices
    • Positive Airway Pressure (PAP) Devices
    • Oral Devices
    • Nasal Devices
    • Chin Straps
    • Others
  • Diagnostic Devices
    • Actigraphs
    • Polysomnography Devices
    • Sleep Screening Devices
    • Others

Therapeutic devices (positive airway pressure (PAP) devices, oral devices, nasal devices, chin straps, and others) held 76.8% of the market share in 2025. They directly address the core need of treating and managing sleep apnea effectively. Devices, such as PAP machines, along with their accompanying masks and accessories, are the primary treatment options recommended by healthcare professionals for OSA. Their ability to provide immediate symptom relief by maintaining airway patency during sleep makes them indispensable for patients. Compared to diagnostic devices, which are used only at initial stages for identifying the disorder, therapeutic devices ensure long-term management, resulting in recurring and consistent demand. Continuous advancements, such as quieter machines, wireless connectivity, portable designs, and more comfortable mask options, also improve patient compliance and adoption. Furthermore, increasing reimbursement support for therapeutic devices in many countries is enhancing affordability and accessibility. As awareness about the health risks of untreated sleep apnea is rising, therapeutic devices remain the cornerstone of treatment, ensuring their dominance in the market.

Analysis by End User:

  • Hospitals and Clinics
  • Sleep Laboratories
  • Homecare Settings

Homecare settings account for 56.9% of the market share. They provide patients with greater convenience, comfort, and independence in managing their condition. Sleep apnea often requires long-term therapy, and patients prefer using CPAP machines, masks, and oral appliances at home rather than making repeated hospital visits. Advancements in device design, including portability, quiet operation, and digital connectivity for remote monitoring, have further made home use simple and effective. This approach also reduces healthcare costs and eases the burden on hospitals and sleep clinics. Insurance coverage and reimbursement for home-use devices have encouraged the adoption, making them accessible to a wider population. Additionally, rising health awareness and the growing importance of preventive care are motivating individuals to integrate therapy into their daily routines at home. As per the sleep apnea devices market forecast, with the ongoing shift towards patient-centric healthcare and increasing aging population, homecare settings will continue to remain the dominant end user segment in the industry.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
  • Turkey
  • Saudi Arabia
  • Iran
  • United Arab Emirates

North America, accounting for a share of 49.2%, enjoys the leading position in the market. The region has a large population suffering from obesity and related lifestyle disorders, which is significantly increasing the incidence of sleep apnea. According to a 2024 study published in the medical journal 'The Lancet', around 3 out of 4 adults in the US were classified as overweight or obese. Widespread awareness about sleep apnea and its health risks, supported by extensive patient education programs, is leading to higher diagnosis and treatment rates compared to other regions. The presence of well-established sleep clinics, research institutions, and specialized healthcare professionals is further strengthening the ecosystem for effective care delivery. In addition, favorable reimbursement policies and broad insurance coverage are making advanced devices like CPAP machines and oral appliances more accessible to patients. Key global players have their headquarters or major operations in North America, enabling faster innovations, product launches, and clinical trials.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SLEEP APNEA DEVICES MARKET ANALYSIS

The United States sleep apnea devices market, holding a share of 87%, is primarily driven by the growing public awareness initiatives led by healthcare providers and advocacy organizations. In accordance with this, the rapid integration of artificial intelligence (AI)-based analytics in diagnostic equipment is enabling real-time data interpretation and personalized treatment strategies, enhancing patient outcomes. Similarly, the expansion of insurance coverage and favorable reimbursement policies is improving access to diagnostic and therapeutic devices. The rise of remote monitoring platforms, which aid in facilitating sleep apnea care delivery in rural and underserved communities, is driving the market expansion. Additionally, the increasing prevalence of lifestyle-related conditions, such as obesity and hypertension, is catalyzing the demand for sleep apnea management. According to the CDC, from August 2021 to August 2023, 40.3% of adults in the United States were categorized as obese, showing no significant difference between genders. The highest obesity rates were found in adults aged 40-59, in contrast to those aged 20-39 or 60 and above. The numerous collaborations between primary care providers and sleep specialists are strengthening referral networks and fueling the market development. Furthermore, continual advancements in device comfort and usability, which improve patient adherence and therapy success, are impacting the market trends.

EUROPE SLEEP APNEA DEVICES MARKET ANALYSIS

The Europe sleep apnea devices market is experiencing growth due to the rising elderly population, which is more prone to sleep-related conditions. In line with this, increasing cases of diabetes and chronic respiratory illnesses contributing to higher rates of undiagnosed OSA are impelling the market growth. The International Diabetes Federation reported a 9.8% diabetes incidence in the EUR Region, affecting 66 Million people in 2024, with an anticipated 10% rise by 2050. The region also had the highest global number of type 1 diabetes cases, including 419,000 individuals under 20 years. Furthermore, increasing government-backed funding for sleep health programs across the EU is enhancing access to diagnostic services. Rising adoption of mobile health apps and wearable devices, which extend patient self-monitoring, is strengthening the market growth. Additionally, updated workplace safety mandates in the transportation and logistics sectors, encouraging regular sleep assessments, are fostering the market expansion. The growth of dedicated sleep clinics and multilingual telehealth platforms is further improving market accessibility.

ASIA-PACIFIC SLEEP APNEA DEVICES MARKET ANALYSIS

The Asia-Pacific market is largely influenced by rising urbanization and lifestyle shifts that have led to an increased incidence of sleep-related disorders. An industry analysis revealed that in 2023, approximately 11% of Indian adults suffered from OSA, with 5% experiencing moderate-to-severe forms of the condition. The occurrence was significantly greater in cities, hitting as high as 19.5%, in contrast to reduced rates in rural areas. In addition to this, escalating air pollution across metropolitan areas is aggravating respiratory conditions, catalyzing the demand for sleep apnea diagnostics and treatment. Similarly, the expansion of private sleep clinics and the adoption of home-based testing services are improving access among middle-income populations. Likewise, the emergence of multilingual digital health platforms supporting higher treatment adherence across linguistically diverse regions is expanding the market scope.

LATIN AMERICA SLEEP APNEA DEVICES MARKET ANALYSIS

The Latin America sleep apnea devices market is advancing due to increasing obesity rates, which are a major risk factor for OSA across several countries in the region. According to NCBI, as of July 2025, 57.5% of men and 62.6% of women were classified as overweight in Brazil, underscoring the growing concern about obesity as a significant public health challenge. Furthermore, the expansion of private healthcare infrastructure is improving access to diagnostic and therapeutic services. The growth in health insurance coverage across urban populations is also enabling more patients to seek timely evaluation and treatment for sleep disorders. Moreover, the ongoing educational initiatives by respiratory health organizations are enhancing physician training and public awareness, fostering early diagnosis and the implementation of effective treatment strategies.

MIDDLE EAST AND AFRICA SLEEP APNEA DEVICES MARKET ANALYSIS

The Middle East and Africa market is gaining traction due to the rising burden of non-communicable diseases, such as diabetes and hypertension, which are strongly associated with sleep apnea. According to an industry analysis, the MENA region had a hypertension prevalence rate of 26.2% in 2024. Similarly, increasing investments in healthcare infrastructure, especially in Gulf Cooperation Council (GCC) countries, and enhancing diagnostic capabilities are supporting the market development. The growing presence of international medical device manufacturers through distribution partnerships is improving product availability across the region. Apart from this, the ongoing shift towards telehealth and mobile health solutions is broadening the access to sleep apnea screening and follow-up care in remote and underserved areas.

COMPETITIVE LANDSCAPE:

Key players are investing heavily in research and working to expand the access to advanced treatment solutions. Leading companies continuously introduce improved CPAP machines, masks, and oral appliances that focus on comfort, portability, and digital connectivity to enhance patient compliance. Their strong distribution networks and partnerships with hospitals, sleep clinics, and healthcare providers ensure wide product availability and adoption. Through marketing campaigns and patient education initiatives, they are also generating awareness about sleep apnea and the benefits of timely treatment. Additionally, key players are collaborating with insurance providers to improve reimbursement frameworks, making therapies more affordable. By setting industry standards, spending on training programs, and exploring new markets, these companies are significantly shaping the market growth and strengthening the global sleep apnea devices landscape. For instance, in August 2024, Inspire Medical Systems gained FDA approval for its Inspire V neurostimulator designed for OSA. The implant boosted efficiency by shortening procedure duration and allowing firmware upgrades. The launch was scheduled for late 2024, followed by a complete rollout in 2025.

The report provides a comprehensive analysis of the competitive landscape in the sleep apnea devices market with detailed profiles of all major companies, including:

  • BMC Medical Co.
  • Braebon Medical Corporation
  • Cadwell Laboratories Inc.
  • CareFusion Corp.
  • Curative Medical Inc.
  • Devilbiss Healthcare
  • Fisher & Paykel Healthcare
  • GE Healthcare
  • Invacare
  • Oventus Medical
  • Panthera Dental
  • ResMed
  • Somnomed Ltd.
  • Vyaire Medical Inc.
  • Whole You Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the sleep apnea devices market?

2. What is the future outlook of sleep apnea devices market?

3. What are the key factors driving the sleep apnea devices market?

4. Which region accounts for the largest sleep apnea devices market share?

5. Which are the leading companies in the global sleep apnea devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Sleep Apnea Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Therapeutic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Positive Airway Pressure (PAP) Devices
        • 6.1.2.1.1 Market Trends
        • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Oral Devices
        • 6.1.2.2.1 Market Trends
        • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Nasal Devices
        • 6.1.2.3.1 Market Trends
        • 6.1.2.3.2 Market Forecast
      • 6.1.2.4 Chin Straps
        • 6.1.2.4.1 Market Trends
        • 6.1.2.4.2 Market Forecast
      • 6.1.2.5 Others
        • 6.1.2.5.1 Market Trends
        • 6.1.2.5.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Breakup by Type
      • 6.2.2.1 Actigraphs
        • 6.2.2.1.1 Market Trends
        • 6.2.2.1.2 Market Forecast
      • 6.2.2.2 Polysomnography Devices
        • 6.2.2.2.1 Market Trends
        • 6.2.2.2.2 Market Forecast
      • 6.2.2.3 Sleep Screening Devices
        • 6.2.2.3.1 Market Trends
        • 6.2.2.3.2 Market Forecast
      • 6.2.2.4 Others
        • 6.2.2.4.1 Market Trends
        • 6.2.2.4.2 Market Forecast
    • 6.2.3 Market Forecast

7 Market Breakup by End-User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sleep Laboratories
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Homecare Settings
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Germany
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 France
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 United Kingdom
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 Italy
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Spain
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Russia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 China
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 Japan
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 India
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 South Korea
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Australia
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Indonesia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Argentina
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
    • 8.4.4 Colombia
      • 8.4.4.1 Market Trends
      • 8.4.4.2 Market Forecast
    • 8.4.5 Chile
      • 8.4.5.1 Market Trends
      • 8.4.5.2 Market Forecast
    • 8.4.6 Peru
      • 8.4.6.1 Market Trends
      • 8.4.6.2 Market Forecast
    • 8.4.7 Others
      • 8.4.7.1 Market Trends
      • 8.4.7.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Turkey
      • 8.5.1.1 Market Trends
      • 8.5.1.2 Market Forecast
    • 8.5.2 Saudi Arabia
      • 8.5.2.1 Market Trends
      • 8.5.2.2 Market Forecast
    • 8.5.3 Iran
      • 8.5.3.1 Market Trends
      • 8.5.3.2 Market Forecast
    • 8.5.4 United Arab Emirates
      • 8.5.4.1 Market Trends
      • 8.5.4.2 Market Forecast
    • 8.5.5 Others
      • 8.5.5.1 Market Trends
      • 8.5.5.2 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Competitive Landscape

  • 12.1 Market Structure
  • 12.2 Key Players
  • 12.3 Profiles of Key Players
    • 12.3.1 BMC Medical Co.
      • 12.3.1.1 Company Overview
      • 12.3.1.2 Product Portfolio
    • 12.3.2 Braebon Medical Corporation
      • 12.3.2.1 Company Overview
      • 12.3.2.2 Product Portfolio
    • 12.3.3 Cadwell Laboratories Inc.
      • 12.3.3.1 Company Overview
      • 12.3.3.2 Product Portfolio
    • 12.3.4 CareFusion Corp.
      • 12.3.4.1 Company Overview
      • 12.3.4.2 Product Portfolio
    • 12.3.5 Curative Medical Inc.
      • 12.3.5.1 Company Overview
      • 12.3.5.2 Product Portfolio
    • 12.3.6 Devilbiss Healthcare
      • 12.3.6.1 Company Overview
      • 12.3.6.2 Product Portfolio
    • 12.3.7 Fisher & Paykel Healthcare
      • 12.3.7.1 Company Overview
      • 12.3.7.2 Product Portfolio
      • 12.3.7.3 Financials
    • 12.3.8 GE Healthcare
      • 12.3.8.1 Company Overview
      • 12.3.8.2 Product Portfolio
    • 12.3.9 Invacare
      • 12.3.9.1 Company Overview
      • 12.3.9.2 Product Portfolio
      • 12.3.9.3 Financials
      • 12.3.9.4 SWOT Analysis
    • 12.3.10 Oventus Medical
      • 12.3.10.1 Company Overview
      • 12.3.10.2 Product Portfolio
      • 12.3.10.3 Financials
    • 12.3.11 Panthera Dental
      • 12.3.11.1 Company Overview
      • 12.3.11.2 Product Portfolio
    • 12.3.12 ResMed
      • 12.3.12.1 Company Overview
      • 12.3.12.2 Product Portfolio
      • 12.3.12.3 Financials
      • 12.3.12.4 SWOT Analysis
    • 12.3.13 Somnomed Ltd.
      • 12.3.13.1 Company Overview
      • 12.3.13.2 Product Portfolio
      • 12.3.13.3 Financials
    • 12.3.14 Vyaire Medical Inc.
      • 12.3.14.1 Company Overview
      • 12.3.14.2 Product Portfolio
    • 12.3.15 Whole You Inc.
      • 12.3.15.1 Company Overview
      • 12.3.15.2 Product Portfolio

List of Figures

  • Figure 1: Global: Sleep Apnea Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Sleep Apnea Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Sleep Apnea Devices Market: Breakup by Device Type (in %), 2025
  • Figure 4: Global: Sleep Apnea Devices Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Sleep Apnea Devices Market: Breakup by End-User (in %), 2025
  • Figure 6: Global: Sleep Apnea Devices Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Sleep Apnea Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Sleep Apnea Therapeutic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Sleep Apnea Therapeutic Devices Market: Breakup by Type (in %), 2025
  • Figure 10: Global: Sleep Apnea Therapeutic Devices (Positive Airway Pressure Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Sleep Apnea Therapeutic Devices (Positive Airway Pressure Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Sleep Apnea Therapeutic Devices (Oral Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Sleep Apnea Therapeutic Devices (Oral Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Sleep Apnea Therapeutic Devices (Nasal Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Sleep Apnea Therapeutic Devices (Nasal Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Sleep Apnea Therapeutic Devices (Chin Straps) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Sleep Apnea Therapeutic Devices (Chin Straps) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Sleep Apnea Therapeutic Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Sleep Apnea Therapeutic Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Sleep Apnea Therapeutic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Sleep Apnea Diagnostic Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Sleep Apnea Diagnostic Devices Market: Breakup by Type (in %), 2025
  • Figure 23: Global: Sleep Apnea Diagnostic Devices (Actigraphs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Sleep Apnea Diagnostic Devices (Actigraphs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Sleep Apnea Diagnostic Devices (Polysomnography Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Sleep Apnea Diagnostic Devices (Polysomnography Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Sleep Apnea Diagnostic Devices (Sleep Screening Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Sleep Apnea Diagnostic Devices (Sleep Screening Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Sleep Apnea Diagnostic Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Sleep Apnea Diagnostic Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Sleep Apnea Diagnostic Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Sleep Apnea Devices (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Sleep Apnea Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Sleep Apnea Devices (Sleep Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Sleep Apnea Devices (Sleep Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Sleep Apnea Devices (Homecare Settings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Sleep Apnea Devices (Homecare Settings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Sleep Apnea Devices (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Sleep Apnea Devices (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Asia Pacific: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Asia Pacific: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: China: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: China: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Japan: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Japan: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: India: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: India: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: South Korea: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: South Korea: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Australia: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Australia: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Indonesia: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Indonesia: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Argentina: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Argentina: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Colombia: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Colombia: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Chile: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Chile: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Peru: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Peru: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Others: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Others: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Middle East and Africa: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Middle East and Africa: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Turkey: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Turkey: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Saudi Arabia: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Saudi Arabia: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Iran: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 101: Iran: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: United Arab Emirates: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 103: United Arab Emirates: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 104: Others: Sleep Apnea Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 105: Others: Sleep Apnea Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 106: Global: Sleep Apnea Devices Industry: SWOT Analysis
  • Figure 107: Global: Sleep Apnea Devices Industry: Value Chain Analysis
  • Figure 108: Global: Sleep Apnea Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Sleep Apnea Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Sleep Apnea Devices Market Forecast: Breakup by Device Type (in Million USD), 2026-2034
  • Table 3: Global: Sleep Apnea Devices Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 4: Global: Sleep Apnea Devices Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 5: Global: Sleep Apnea Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Sleep Apnea Devices Market: Competitive Structure
  • Table 7: Global: Sleep Apnea Devices Market: Key Players